Drugs for Neglected Diseases initiative

Vision To improve the quality of life and the health of people suffering from neglected diseases by using an alternative model to develop drugs for these diseases and ensuring equitable access to new and field relevant health tools. Mission DNDi will develop new drugs or new formulations of existing drugs for patients suffering from the most neglected communicable diseases. Acting in the public interest, it will bridge the existing R&D gaps in essential drugs for these diseases by initiating and coordinating drug R&D projects in collaboration with the international research community, the public sector, the pharmaceutical industry, and other relevant partners. DNDi will address unmet needs by taking on projects that others are unable or unwilling to pursue. Although DNDi's primary focus will be the development of drugs for the most neglected diseases such as sleeping sickness, kala-azar, and Chagas disease, it will also consider engaging R&D projects on other neglected diseases.